Evaluation of prostatic cancer prevalence in patients with prostatic-specific antigen between 4 and 10 and normal digital rectal examination.

Tadayon, Farhad; Arezegar, Hamid Reza; Khorrami, Mohammad Hatef; Hashemi Juzdani, Rasoul; Shahdoost, Amir Abbas; Mellat, Mehdi

Tadayon, Farhad; Arezegar, Hamid Reza; Khorrami, Mohammad Hatef; Hashemi Juzdani, Rasoul; Shahdoost, Amir Abbas; Mellat, Mehdi.

Afiliación

Tadayon F; Department of Urology, Isfahan University of Medical Science, Isfahan, Iran.
Arezegar HR; Department of Urology, Isfahan University of Medical Science, Isfahan, Iran.
Khorrami MH; Department of Urology, Isfahan University of Medical Science, Isfahan, Iran.
Hashemi Juzdani R; Department of Urology, Isfahan University of Medical Science, Isfahan, Iran.
Shahdoost AA; Department of Urology, Isfahan University of Medical Science, Isfahan, Iran.
Mellat M; Department of Urology, Isfahan University of Medical Science, Isfahan, Iran.

Adv Biomed Res ; 5: 112, 2016.

Article en En | MEDLINE | ID: mdl-27403407

Palabras clave

Benign prostatic hyperplasia; digital rectal examination; percentage of free prostate-specific antigen; prostate cancer; prostate-specific antigen; prostate-specific antigen density

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Adv Biomed Res Año: 2016 Tipo del documento: Article País de afiliación: Irán Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google